Biofrontera Incorporated et al. vs. DUSA Pharmaceuticals Inc. et al.
Explore the PTAB proceeding IPR2018-01586 filed by Biofrontera Incorporated et al. on 2018-08-22. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2018-01586
Filing Date
2018-08-22
Accorded Filing Date
2018-08-22
Institution Decision Date
2019-02-26
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
โ
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Biofrontera Incorporated et al.
Represented By
Thompson, Rachelleet alPatent Owner / Respondent
DUSA Pharmaceuticals Inc. et al.
Represented By
Renner, Walteret alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 2800 - Semiconductors, Electrical & Optical Systems
Decisions Rendered
0 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 32904 | Michael Kaminski | +1 202-672-5490 |
| 34038 | Gilberto Villacorta | +1 202-295-4199 |
| 34202 | Antoinette Konski | +1 650-856-3700 |
| 34702 | Andrew Rawlins | +1 202-672-5349 |
| 34717 | Michele Simkin | +1 202-672-5530 |
| 35264 | Stephen Maebius | +1 202-672-5569 |
| 35421 | Joseph Ziebert | +1 414-297-5768 |
| 37288 | Courtenay Brinckerhoff | +1 202-672-5300 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,723,991 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 6,223,071 B1 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 6,709,446 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 7,190,109 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 7,723,910 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,030,836 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,216,289 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,758,418 B2 | US Continuation / Sibling | View Official Patent → |
Biofrontera Incorporated et al. v. DUSA Pharmaceuticals Inc. et al.
DUSA Pharmaceuticals, Inc. v. Biofrontera Inc.